An Cheng

10PUBLICATIONS

14CO-AUTHORS

PharmacogenomicsMedical biochemistry - lipidsNeurology and neuromuscular diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 29, 2026

Dopamine D2 Receptors, D1/D2 Receptor Heteromers and CaMKII Signaling in the Neurobiology of Drug Addiction.

|Oct 15, 2025

Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration.

Chuantao Wu, Jiejing Lin, Qikai Chen

|Apr 21, 2023

Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation.

An Cheng, Ichiro Kawahata, Yifei Wang

|Apr 13, 2023

Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors in Mice by an FABP3 Inhibitor.

Wenbin Jia, Ichiro Kawahata, An Cheng

|Sep 09, 2022

Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets.

Qingyun Guo, Ichiro Kawahata, An Cheng

|Jun 02, 2021

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy.

An Cheng, Wenbin Jia, Ichiro Kawahata

Pageof 2

Frequent Collaborators

Ichiro Kawahata

Kohji Fukunaga

Wenbin Jia

Dian Yuan

Yifei Wang

Yasuharu Shinoda

Qingyun Guo

Haoyang Wang

Toshikuni Sasaoka

Atsushi Takeda

Frequent Collaborators

Ichiro Kawahata

Kohji Fukunaga

Wenbin Jia

Dian Yuan